arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 2/2016 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    REVIEW

    On the benefit of standard vaccines: tetanus

    NEW ON THE MARKET

    Idarucizumab (PRAXBIND): antidote for dabigatran

    a-t READER'S QUESTIONS AND COMMENTS

    Red yeast rice: withdrawal of products from the market is overdue

    Is it allowed to substitute immediate-release preparations for prolonged-release preparations?

    IN BRIEF

    Rivaroxaban (XARELTO) rehabilitated?

    Betahistine (e.g. VASOMOTAL) for MENIÈRE´s disease

    Fusafungine (LOCABIOSOL): withdrawal from the market recommended

    Misleading trade names of painkillers

    Error analysis: BIA 10-2474 in phase 1 testing

    CURRENT ADR NETWORK REPORT

    Urinary incontinence due to safinamide (XADAGO)?
    free

    e a-t IN THE INTERNET

    Dimethyl fumarate (TECFIDERA): first progressive multifocal leukoencephalopathy with only moderate lymphopenia

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles